Canilang, Baby Boy .

HRN: 25-29-31  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2024
CEFOTAXIME 500MG (VIAL)
06/23/2024
06/30/2024
IV
125 Mg
Q 12
T/C Neonatal Sepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: